| Primary |
| Nephrogenic Anaemia |
22.6% |
| Renal Failure Chronic |
15.5% |
| Diabetic Nephropathy |
9.5% |
| Nephrosclerosis |
8.6% |
| Anaemia Of Malignant Disease |
6.7% |
| Glomerulonephritis Chronic |
6.4% |
| Anaemia |
4.7% |
| Cardiac Failure |
4.4% |
| Hypertension |
3.6% |
| Dialysis |
2.4% |
| Chemotherapy |
2.3% |
| Nausea |
1.9% |
| Prophylaxis |
1.7% |
| Vomiting |
1.7% |
| Pain |
1.5% |
| Product Used For Unknown Indication |
1.5% |
| Constipation |
1.4% |
| Gastritis |
1.4% |
| Nephrotic Syndrome |
1.3% |
| Diabetes Mellitus |
0.8% |
|
| Sudden Death |
8.7% |
| Hypertension |
7.4% |
| Renal Failure |
7.4% |
| Renal Failure Chronic |
7.4% |
| Death |
6.0% |
| Pulmonary Embolism |
6.0% |
| Myocardial Infarction |
5.4% |
| Thrombocytopenia |
5.4% |
| Blood Creatinine Increased |
4.7% |
| Hyperkalaemia |
4.7% |
| Pneumonia |
4.7% |
| Cardiac Failure Congestive |
4.0% |
| Loss Of Consciousness |
4.0% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
4.0% |
| Cardiac Failure |
3.4% |
| Gastroenteritis |
3.4% |
| Haematuria |
3.4% |
| Haemolytic Anaemia |
3.4% |
| Peripheral Arterial Occlusive Disease |
3.4% |
| Renal Impairment |
3.4% |
|
| Secondary |
| Nephrogenic Anaemia |
30.8% |
| Nephrosclerosis |
15.4% |
| Diabetic Nephropathy |
14.5% |
| Glomerulonephritis Chronic |
12.0% |
| Product Used For Unknown Indication |
6.8% |
| Hypertension |
6.3% |
| Prophylaxis |
1.9% |
| Prurigo |
1.6% |
| Gastritis |
1.3% |
| Acute Myeloid Leukaemia |
1.2% |
| Breast Cancer |
1.0% |
| Hyperuricaemia |
1.0% |
| Diabetes Mellitus |
1.0% |
| Nephritis |
0.9% |
| Anaemia |
0.8% |
| Nephrotic Syndrome |
0.7% |
| Angina Pectoris |
0.7% |
| Breast Cancer Metastatic |
0.7% |
| Diffuse Large B-cell Lymphoma |
0.7% |
| Renal Failure Chronic |
0.6% |
|
| Renal Impairment |
11.6% |
| Renal Failure |
10.8% |
| Cardiac Failure |
10.6% |
| Cardiac Failure Congestive |
7.7% |
| Sudden Death |
5.8% |
| Death |
5.1% |
| Neoplasm Skin |
4.6% |
| Spinal Column Stenosis |
4.1% |
| Sepsis |
3.9% |
| Peripheral Arterial Occlusive Disease |
3.6% |
| Cerebellar Infarction |
3.4% |
| Hypertension |
3.4% |
| Myocardial Infarction |
3.4% |
| Tumour Marker Increased |
3.4% |
| Duodenal Ulcer Perforation |
3.1% |
| Fall |
3.1% |
| Metastases To Lymph Nodes |
3.1% |
| Pseudomembranous Colitis |
3.1% |
| Renal Failure Chronic |
3.1% |
| Tracheostomy |
3.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
27.8% |
| Product Used For Unknown Indication |
24.4% |
| Hypertension |
6.4% |
| Anaemia |
5.6% |
| Multiple Myeloma |
3.9% |
| Nuclear Magnetic Resonance Imaging |
3.9% |
| Prophylaxis |
3.7% |
| Pain |
3.7% |
| Breast Cancer |
3.5% |
| Hyperparathyroidism Secondary |
2.9% |
| Renal Transplant |
2.1% |
| Osteoporosis |
1.7% |
| Immunosuppression |
1.5% |
| Renal Failure Chronic |
1.5% |
| Prophylaxis Against Transplant Rejection |
1.5% |
| Nausea |
1.3% |
| Angiogram |
1.1% |
| Non-small Cell Lung Cancer |
1.1% |
| Constipation |
1.1% |
| Infection |
1.1% |
|
| Urinary Tract Infection |
7.8% |
| Wound Infection Staphylococcal |
7.2% |
| Renal Failure |
6.5% |
| Respiratory Tract Infection |
6.5% |
| Weight Decreased |
6.1% |
| Neutropenia |
5.8% |
| Renal Failure Acute |
5.8% |
| Vomiting |
5.8% |
| Pneumonia |
4.4% |
| Pyrexia |
4.4% |
| Renal Impairment |
4.4% |
| Thrombocytopenia |
4.4% |
| Dyspnoea |
4.1% |
| Myositis |
4.1% |
| Nephrogenic Systemic Fibrosis |
4.1% |
| Sepsis |
4.1% |
| Deep Vein Thrombosis |
3.8% |
| Pulmonary Embolism |
3.8% |
| Anaemia |
3.4% |
| Colon Cancer |
3.4% |
|
| Interacting |
| Product Used For Unknown Indication |
60.9% |
| Pain |
17.4% |
| Diabetes Mellitus Management |
8.7% |
| Hepatitis C |
8.7% |
| Anaemia |
4.3% |
|
| Rash |
40.0% |
| Swelling |
40.0% |
| Haemolytic Anaemia |
20.0% |
|
